18F-flortaucipir PET showed a gradient of tau binding from PD-NC (none or minimal) via PD-MCI (minimal) and PDD (low/modest) to DLB (intermediate/strong) and finally to AD (highest) [381], tau uptake in PDD being intermediate between PD-ND and AD [213]. This evidence concerns the gene MAPT and Alzheimer disease.